An Annual General Meeting of The Cochrane Collaboration (Cochrane) was held on Monday 4 September 2023 at the QEII Conference Centre in London.
For those who wish to revisit the AGM or missed the event, you can access the meeting agenda, presentations, and view the meeting video here. The minutes will follow.
Members approved the following…
At a joint face to face meeting in London on Sunday 3 September 2023, the Governing Board and the Council agreed to work in partnership to develop new and improved ways of engaging with the Cochrane Community.
The Council as it currently exists will not continue after the end of this year and a new Advisory Panel will be established to gather…
The Governing Board met in London on Thursday 31 August, Friday 1 September and Saturday 2 September. Members of the Governing Board are Cochrane’s Trustees and are responsible for the charity’s management and administration. The Board usually meets quarterly, two of the meetings are online and two are in person. Below is a summary of the meeting…
Every year Cochrane recognizes the outstanding work of Kenneth Warren, a scientist, extremely influential in drawing attention to the 'great neglected diseases' that plague people in developing countries. He prioritized the need for valid summaries of key research studies and to the way electronic media could be used to disseminate results of…
Dr Thomas Chalmers was an outspoken advocate of randomised trials, whether at the bedside, at professional meetings, in class or in situations pertaining to his own life. His creativity spanned his entire career, influencing clinicians and methodologists alike. He is perhaps best known for the notion ‘randomise the first patient’, his belief…
Dr Tom Chalmers was an outspoken advocate of randomised trials, whether at the bedside, at professional meetings, in class or in situations pertaining to his own life. His creativity spanned his entire career, influencing clinicians and methodologists alike. He is perhaps best known for the notion ‘randomise the first patient’, his belief that it…
Dr Tom Chalmers was an outspoken advocate of randomised trials, whether at the bedside, at professional meetings, in class or in situations pertaining to his own life. His creativity spanned his entire career, influencing clinicians and methodologists alike. He is perhaps best known for the notion ‘randomise the first patient’, his belief that it…
William (Bill) Silverman (1924-2004) was one of the founders of American neonatal medicine. He was honoured repeatedly as one of the pioneers in his specialty; however, he often evoked somewhat contradictory responses amongst his colleagues because he was in the habit of raising troubling questions about the scientific basis and ethics of his and…
Anne Anderson was a contributor to the stream of thinking and effort that gave birth to evidence-based health care. A clinically qualified reproductive physiologist, Anne had an active interest in women’s health, co-editing the first edition of Women’s Problems in General Practice with Ann McPherson and contributed to Effectiveness and…
Dr. Chris Silagy was the founding Director of the Australasian Cochrane Centre and instrumental in Cochrane's development and success. Chris was energetic, positive and inspiring. Before his death in December 2001, Chris expressed a wish for a Fund to be established, to be held by the Monash Foundation. Chris initiated this fund with his own…
Cochrane is an international organization but is legally registered in the United Kingdom as a UK Charity and a Limited Liability Company. Cochrane's Governing Board comprises at least 13 people, who are both Trustees of the Charity and Directors of the Company. More than half of the Trustees are elected by and from Cochrane's members; with the…
Cochrane is proud to be one of the world’s leading producers of trusted evidence. To maintain that standard, we need to innovate and make sure we are meeting the needs of the people using our evidence. We are making some major changes, one of which is the introduction of a new focused review format. We're simplifying and streamlining our review…
Roses Parker started with Cochrane in 2019 as a Network Support Fellow and is now a Commissioning Editor in the Evidence Production and Methods Directorate. Roses has previously held roles as a Staff Nurse, Data Analyst, and Research Assistant, all standing her in good stead for the role. Here, Roses explains how her new role will help…
We are delighted to announce the launch of the first complete version and print edition of the Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy. After substantive work over the years, this version is now freely available online via the Cochrane Training website and in printed and e-book form, which can be purchased from the…
Cochrane was founded in 1993 and has grown into a global network producing gold standard evidence syntheses. Over those years we’ve been doing things the same way and the field has evolved during that time. To maintain our place as one of the world’s leaders in producing trusted evidence, we are making some big changes in 2023 so that we can more…
The Governing Board met face-to-face in Paris in 20 May 2023. Members of the Board are Trustees of the Cochrane Charity and have overall responsibility for ensuring that Cochrane complies with our governing document, Charity Commission regulations and the law. The Co- Chairs of Council are members of the Governing Board but are not Trustees, they…
Cochrane is dedicated to improving the maintenance of our reviews and enhancing access to clear, useful health information.
As part of this, Cochrane will be changing the reporting guidance that our authors use. We will be using publishing standard guidelines, such as the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA…
Cochrane has now fully upgraded to RevMan Web, meaning RevMan 5, the desktop version, is no longer available. Authors now have access to a new data management feature – study centric data - when creating new reviews. For ongoing protocols and reviews, switching this feature on is simple and can be done yourself.
Overview of study centric…
Nominate your Cochrane colleagues for prizes and awards by 12 June 2023.
Every year Cochrane awards members of its Community with a range of prizes that highlight high-quality methodological research, supporting health decision-making in developing countries, and contributors who have made a significant contribution to the organization.
The…
Today marks the closure of the UK-based Cochrane Review Groups whose funding from the National Institute for Health and Care Research (NIHR) has come to an end.
Over Cochrane’s 30-year history, thanks to the work of Cochrane Review Groups, over 16,000 new and updated Cochrane Reviews have been published covering a wide range of disciplines. These…
An Annual General Meeting of The Cochrane Collaboration (Cochrane) was held on Monday 4 September 2023 at the QEII Conference Centre in London. For those who wish to revisit the AGM or missed the event, you can access the meeting agenda, presentations, and view the meeting video here. The minutes will follow. Members approved the following…
At a joint face to face meeting in London on Sunday 3 September 2023, the Governing Board and the Council agreed to work in partnership to develop new and improved ways of engaging with the Cochrane Community. The Council as it currently exists will not continue after the end of this year and a new Advisory Panel will be established to gather…
The Governing Board met in London on Thursday 31 August, Friday 1 September and Saturday 2 September. Members of the Governing Board are Cochrane’s Trustees and are responsible for the charity’s management and administration. The Board usually meets quarterly, two of the meetings are online and two are in person. Below is a summary of the meeting…
Every year Cochrane recognizes the outstanding work of Kenneth Warren, a scientist, extremely influential in drawing attention to the 'great neglected diseases' that plague people in developing countries. He prioritized the need for valid summaries of key research studies and to the way electronic media could be used to disseminate results of…
Dr Thomas Chalmers was an outspoken advocate of randomised trials, whether at the bedside, at professional meetings, in class or in situations pertaining to his own life. His creativity spanned his entire career, influencing clinicians and methodologists alike. He is perhaps best known for the notion ‘randomise the first patient’, his belief…
Dr Tom Chalmers was an outspoken advocate of randomised trials, whether at the bedside, at professional meetings, in class or in situations pertaining to his own life. His creativity spanned his entire career, influencing clinicians and methodologists alike. He is perhaps best known for the notion ‘randomise the first patient’, his belief that it…
Dr Tom Chalmers was an outspoken advocate of randomised trials, whether at the bedside, at professional meetings, in class or in situations pertaining to his own life. His creativity spanned his entire career, influencing clinicians and methodologists alike. He is perhaps best known for the notion ‘randomise the first patient’, his belief that it…
William (Bill) Silverman (1924-2004) was one of the founders of American neonatal medicine. He was honoured repeatedly as one of the pioneers in his specialty; however, he often evoked somewhat contradictory responses amongst his colleagues because he was in the habit of raising troubling questions about the scientific basis and ethics of his and…
Anne Anderson was a contributor to the stream of thinking and effort that gave birth to evidence-based health care. A clinically qualified reproductive physiologist, Anne had an active interest in women’s health, co-editing the first edition of Women’s Problems in General Practice with Ann McPherson and contributed to Effectiveness and…
Dr. Chris Silagy was the founding Director of the Australasian Cochrane Centre and instrumental in Cochrane's development and success. Chris was energetic, positive and inspiring. Before his death in December 2001, Chris expressed a wish for a Fund to be established, to be held by the Monash Foundation. Chris initiated this fund with his own…
Cochrane is an international organization but is legally registered in the United Kingdom as a UK Charity and a Limited Liability Company. Cochrane's Governing Board comprises at least 13 people, who are both Trustees of the Charity and Directors of the Company. More than half of the Trustees are elected by and from Cochrane's members; with the…
Cochrane is proud to be one of the world’s leading producers of trusted evidence. To maintain that standard, we need to innovate and make sure we are meeting the needs of the people using our evidence. We are making some major changes, one of which is the introduction of a new focused review format. We're simplifying and streamlining our review…
Roses Parker started with Cochrane in 2019 as a Network Support Fellow and is now a Commissioning Editor in the Evidence Production and Methods Directorate. Roses has previously held roles as a Staff Nurse, Data Analyst, and Research Assistant, all standing her in good stead for the role. Here, Roses explains how her new role will help…
We are delighted to announce the launch of the first complete version and print edition of the Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy. After substantive work over the years, this version is now freely available online via the Cochrane Training website and in printed and e-book form, which can be purchased from the…
Cochrane was founded in 1993 and has grown into a global network producing gold standard evidence syntheses. Over those years we’ve been doing things the same way and the field has evolved during that time. To maintain our place as one of the world’s leaders in producing trusted evidence, we are making some big changes in 2023 so that we can more…
The Governing Board met face-to-face in Paris in 20 May 2023. Members of the Board are Trustees of the Cochrane Charity and have overall responsibility for ensuring that Cochrane complies with our governing document, Charity Commission regulations and the law. The Co- Chairs of Council are members of the Governing Board but are not Trustees, they…
Cochrane is dedicated to improving the maintenance of our reviews and enhancing access to clear, useful health information. As part of this, Cochrane will be changing the reporting guidance that our authors use. We will be using publishing standard guidelines, such as the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA…
Cochrane has now fully upgraded to RevMan Web, meaning RevMan 5, the desktop version, is no longer available. Authors now have access to a new data management feature – study centric data - when creating new reviews. For ongoing protocols and reviews, switching this feature on is simple and can be done yourself. Overview of study centric…
Nominate your Cochrane colleagues for prizes and awards by 12 June 2023. Every year Cochrane awards members of its Community with a range of prizes that highlight high-quality methodological research, supporting health decision-making in developing countries, and contributors who have made a significant contribution to the organization. The…
Today marks the closure of the UK-based Cochrane Review Groups whose funding from the National Institute for Health and Care Research (NIHR) has come to an end. Over Cochrane’s 30-year history, thanks to the work of Cochrane Review Groups, over 16,000 new and updated Cochrane Reviews have been published covering a wide range of disciplines. These…